OBJECTIVE: To describe vaccination coverage of the National Immunization Programme (NIP) in the Netherlands for the years 2006-2008. DESIGN: Descriptive, retrospective. METHOD: Vaccination coverage was determined per vaccination and birth cohort based on data from the vaccination-registration system 'Praeventis'. This new system enables more accurate testing for compatibility with NIP guidelines. Furthermore, it was determined on an individual level whether the desired vaccination status was reached before a certain target age (1, 2, 5 or 10 years). RESULTS: In the final year reported, all national vaccination percentages came up to the WHO standards. Vaccination coverage for babies ranged from 94.5% for diphtheria, whooping cough, tetanus and polio (DTaP-IPV) to 96.0% for measles, mumps and rubella (MMR). The coverage for toddlers and school-aged children was over 90% for each of the vaccinations. In 5 of the 12 Dutch provinces and 128 of the 443 municipalities, one or more vaccination percentages were below the standard of 90%. Vaccination coverage for the second MMR vaccination and for hepatitis B vaccination in children of whom one or both parents were born in a country where the incidence of hepatitis B is higher than average, was relatively low (92.5% and 90.7%, respectively). CONCLUSION: Vaccination coverage in the Netherlands is high. In general, vaccination coverage for toddlers and school-aged children requires extra attention. This applies in particular to the second MMR vaccination and to vaccination in children of whom one or both parents were born in a country where the incidence of hepatitis B is higher than average.
OBJECTIVE: To describe vaccination coverage of the National Immunization Programme (NIP) in the Netherlands for the years 2006-2008. DESIGN: Descriptive, retrospective. METHOD: Vaccination coverage was determined per vaccination and birth cohort based on data from the vaccination-registration system 'Praeventis'. This new system enables more accurate testing for compatibility with NIP guidelines. Furthermore, it was determined on an individual level whether the desired vaccination status was reached before a certain target age (1, 2, 5 or 10 years). RESULTS: In the final year reported, all national vaccination percentages came up to the WHO standards. Vaccination coverage for babies ranged from 94.5% for diphtheria, whooping cough, tetanus and polio (DTaP-IPV) to 96.0% for measles, mumps and rubella (MMR). The coverage for toddlers and school-aged children was over 90% for each of the vaccinations. In 5 of the 12 Dutch provinces and 128 of the 443 municipalities, one or more vaccination percentages were below the standard of 90%. Vaccination coverage for the second MMR vaccination and for hepatitis B vaccination in children of whom one or both parents were born in a country where the incidence of hepatitis B is higher than average, was relatively low (92.5% and 90.7%, respectively). CONCLUSION: Vaccination coverage in the Netherlands is high. In general, vaccination coverage for toddlers and school-aged children requires extra attention. This applies in particular to the second MMR vaccination and to vaccination in children of whom one or both parents were born in a country where the incidence of hepatitis B is higher than average.
Authors: Elsemieke D Scheepers; Alies van Lier; Ingrid H Drijfhout; Guy Berbers; Nicoline A T van der Maas; Hester E de Melker; Mirjam J Knol Journal: Eur J Pediatr Date: 2017-04-20 Impact factor: 3.183
Authors: Wilhelmina L M Ruijs; Jeannine L A Hautvast; Giovanna van Ijzendoorn; Wilke J C van Ansem; Koos van der Velden; Marlies E J L Hulscher Journal: BMC Public Health Date: 2012-06-06 Impact factor: 3.295
Authors: Amy van Grieken; Lydian Veldhuis; Carry M Renders; Gerard J Borsboom; Johannes C van der Wouden; Remy A Hirasing; Hein Raat Journal: PLoS One Date: 2013-05-31 Impact factor: 3.240
Authors: Judith Spijkerman; Elske J M van Gils; Reinier H Veenhoven; Eelko Hak; Ed P F Yzerman; Arie van der Ende; Alienke J Wijmenga-Monsuur; Germie P J M van den Dobbelsteen; Elisabeth A M Sanders Journal: Emerg Infect Dis Date: 2011-04 Impact factor: 6.883
Authors: N H T M Dukers-Muijrers; E Stobberingh; P Beisser; R C H Boesten; P Jacobs; C J P A Hoebe Journal: Epidemiol Infect Date: 2012-06-12 Impact factor: 4.434
Authors: Wilhelmina L M Ruijs; Jeannine L A Hautvast; Giovanna van IJzendoorn; Wilke J C van Ansem; Glyn Elwyn; Koos van der Velden; Marlies E J L Hulscher Journal: BMC Health Serv Res Date: 2012-08-01 Impact factor: 2.655
Authors: Wilhelmina L M Ruijs; Jeannine L A Hautvast; Said Kerrar; Koos van der Velden; Marlies E J L Hulscher Journal: BMC Public Health Date: 2013-05-28 Impact factor: 3.295
Authors: Hilde M van Keulen; Wilma Otten; Robert A C Ruiter; Minne Fekkes; Jim van Steenbergen; Elise Dusseldorp; Theo W G M Paulussen Journal: BMC Public Health Date: 2013-02-06 Impact factor: 3.295